Recent research progress of microRNAs in hypertension pathogenesis, with a focus on the roles of miRNAs in pulmonary arterial hypertension

[1]  Zhiguang Sun,et al.  Long noncoding RNA GAPLINC promotes gastric cancer cell proliferation by acting as a molecular sponge of miR-378 to modulate MAPK1 expression , 2018, OncoTargets and therapy.

[2]  N. Arnold,et al.  MicroRNA-1405 p and SMURF 1 regulate pulmonary arterial hypertension , 2018 .

[3]  M. Weiser-Evans.  Smooth Muscle Differentiation Control Comes Full Circle: The Circular Noncoding RNA, circActa2, Functions as a miRNA Sponge to Fine-Tune α-SMA Expression. , 2017, Circulation research.

[4]  S. Breuils-bonnet,et al.  Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[5]  Weifang Zhang,et al.  Negative feedback regulation between microRNA let-7g and LOX-1 mediated hypoxia-induced PASMCs proliferation. , 2017, Biochemical and biophysical research communications.

[6]  ChenCheng,et al.  miR-185/P2Y6 Axis Inhibits Angiotensin II-Induced Human Aortic Vascular Smooth Muscle Cell Proliferation. , 2017 .

[7]  T. Zeller,et al.  microRNAs in cardiovascular disease – clinical application , 2017, Clinical chemistry and laboratory medicine.

[8]  Y J Anupama,et al.  Hypertension is an important risk determinant for chronic kidney disease: results from a cross-sectional, observational study from a rural population in South India , 2017, Journal of Human Hypertension.

[9]  Sung-Hyun Park,et al.  Elevated microRNA-135a is associated with pulmonary arterial hypertension in experimental mouse model , 2017, Oncotarget.

[10]  M. Siedlinski,et al.  Novel Immune Mechanisms in Hypertension and Cardiovascular Risk , 2017, Current Cardiovascular Risk Reports.

[11]  Bo Zhang,et al.  Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease , 2017, Bioscience reports.

[12]  S. Provencher,et al.  The cancer theory of pulmonary arterial hypertension , 2017, Pulmonary circulation.

[13]  P. Vardas,et al.  Low Levels of MicroRNA‐21 Are a Marker of Reduced Arterial Stiffness in Well‐Controlled Hypertension , 2017, Journal of clinical hypertension.

[14]  J. Li,et al.  Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells. , 2017, European review for medical and pharmacological sciences.

[15]  A. Cai,et al.  Circulating miR-92a expression level in patients with essential hypertension: a potential marker of atherosclerosis , 2017, Journal of Human Hypertension.

[16]  Jiyan Chen,et al.  Circulating miRNA29 family expression levels in patients with essential hypertension as potential markers for left ventricular hypertrophy , 2017, Clinical and experimental hypertension.

[17]  S. Archer,et al.  MicroRNA‐138 and MicroRNA‐25 Down‐regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype , 2017, American journal of respiratory and critical care medicine.

[18]  Weifang Zhang,et al.  MicroRNA let‐7g inhibited hypoxia‐induced proliferation of PASMCs via G0/G1 cell cycle arrest by targeting c‐myc , 2017, Life sciences.

[19]  HaiYu Li,et al.  Downregulation of microRNA-34b is responsible for the elevation of blood pressure in spontaneously hypertensive rats , 2017, Molecular medicine reports.

[20]  J. Sluijter,et al.  miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury , 2017, Theranostics.

[21]  Sébastien Bonnet,et al.  Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than “miR” Words , 2017, American journal of respiratory and critical care medicine.

[22]  Z. Massy,et al.  The mir-221/222 Cluster is a Key Player in Vascular Biology via the Fine-Tuning of Endothelial Cell Physiology. , 2016, Current vascular pharmacology.

[23]  M. Huang,et al.  Differential expression of microRNA in the lungs of rats with pulmonary arterial hypertension , 2016, Molecular medicine reports.

[24]  Zhi Chen,et al.  Identification of crucial miRNAs and the targets in renal cortex of hypertensive patients by expression profiles , 2016, Renal failure.

[25]  Qian Zhou,et al.  miR-185/P2Y6 Axis Inhibits Angiotensin II-Induced Human Aortic Vascular Smooth Muscle Cell Proliferation. , 2017, DNA and cell biology.

[26]  P. Foster,et al.  MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases , 2016, Drug Delivery and Translational Research.

[27]  P. Szodoray,et al.  The role of microRNAs in the pathogenesis of autoimmune diseases. , 2016, Autoimmunity reviews.

[28]  M. Humbert,et al.  Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension. , 2016, American journal of respiratory and critical care medicine.

[29]  Haiyan Sang,et al.  Downregulation of microRNA-637 Increases Risk of Hypoxia-Induced Pulmonary Hypertension by Modulating Expression of Cyclin Dependent Kinase 6 (CDK6) in Pulmonary Smooth Muscle Cells , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[30]  S. Joshi,et al.  MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension. , 2016, American journal of physiology. Heart and circulatory physiology.

[31]  Xiang-Dong Fu,et al.  MicroRNA-21 Lowers Blood Pressure in Spontaneous Hypertensive Rats by Upregulating Mitochondrial Translation. , 2016, Circulation.

[32]  Yingli Song,et al.  miRNA‐34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA , 2016, Cell proliferation.

[33]  A. Gjesing,et al.  Renin angiotensinogen system gene polymorphisms and essential hypertension among people of West African descent: a systematic review , 2016, Journal of Human Hypertension.

[34]  D. Zheng,et al.  MicroRNA-153 targeting of KCNQ4 contributes to vascular dysfunction in hypertension , 2016, Cardiovascular research.

[35]  Mai Chen,et al.  Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2 , 2016, Scientific Reports.

[36]  N. Arnold,et al.  MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension. , 2016, The Journal of clinical investigation.

[37]  Ran Wang,et al.  MicroRNA-26b attenuates monocrotaline-induced pulmonary vascular remodeling via targeting connective tissue growth factor (CTGF) and cyclin D1 (CCND1) , 2016, Oncotarget.

[38]  Z. Jing,et al.  Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension , 2016, Journal of Molecular Medicine.

[39]  Guanghui Liu,et al.  MiRNA-199a-5p influences pulmonary artery hypertension via downregulating Smad3. , 2016, Biochemical and biophysical research communications.

[40]  M. Rojas,et al.  MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension , 2016, PloS one.

[41]  Yan Zeng,et al.  MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells , 2016, Scientific Reports.

[42]  J. Xu,et al.  MiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression. , 2016, Biochemical and biophysical research communications.

[43]  Yang Jiao,et al.  MicroRNA-145 regulates platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration by targeting CD40. , 2016, American journal of translational research.

[44]  A. Olschewski,et al.  Microarray analysis in pulmonary hypertension , 2016, European Respiratory Journal.

[45]  Yu-qing Huang,et al.  Circulating miR155 expression level is positive with blood pressure parameters: Potential markers of target-organ damage , 2016, Clinical and experimental hypertension.

[46]  Weifang Zhang,et al.  MiR-590-5p-meidated LOX-1 upregulation promotes Angiotensin II-induced endothelial cell apoptosis. , 2016, Biochemical and biophysical research communications.

[47]  Indu Mohan,et al.  Trends in Coronary Heart Disease Epidemiology in India. , 2016, Annals of global health.

[48]  Wei-Hua Wu,et al.  MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β. , 2016, Life sciences.

[49]  F. Perros,et al.  MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer? , 2016, Current opinion in oncology.

[50]  Chenchen,et al.  MicroRNA-21 Lowers Blood Pressure in Spontaneous Hypertensive Rats by Upregulating Mitochondrial Translation , 2016 .

[51]  B. Kang,et al.  Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling. , 2016, American journal of respiratory cell and molecular biology.

[52]  Wei Zhao,et al.  Down-regulation of the miR-543 alleviates insulin resistance through targeting the SIRT1. , 2015, Biochemical and biophysical research communications.

[53]  I. Elmadfa,et al.  The role of dietary potassium in hypertension and diabetes , 2015, Journal of Physiology and Biochemistry.

[54]  Yu Lu,et al.  Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit. , 2015, Cell reports.

[55]  J. McClure,et al.  MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension. , 2015, Circulation research.

[56]  Xiao-hui Li,et al.  miR-100 suppresses mTOR signaling in hypoxia-induced pulmonary hypertension in rats. , 2015, European journal of pharmacology.

[57]  Salil Sharma,et al.  Role of miR206 in genistein-induced rescue of pulmonary hypertension in monocrotaline model. , 2015, Journal of applied physiology.

[58]  F. Perros,et al.  miR-223 reverses experimental pulmonary arterial hypertension. , 2015, American journal of physiology. Cell physiology.

[59]  P. Pibarot,et al.  Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension , 2022 .

[60]  C. Tayade,et al.  Differential expression of plasma microRNA in preeclamptic patients at delivery and 1 year postpartum. , 2015, American journal of obstetrics and gynecology.

[61]  Ying Shi,et al.  MicroRNA-1 regulates the proliferation of vascular smooth muscle cells by targeting insulin-like growth factor 1. , 2015, International journal of molecular medicine.

[62]  S. Breuils-bonnet,et al.  Bromodomain-Containing Protein 4Novelty and Significance , 2015 .

[63]  S. Joshi,et al.  Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[64]  B. Kang,et al.  PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21 , 2015, PloS one.

[65]  Yan Zeng,et al.  Hypoxia inducible factor-1 mediates expression of miR-322: potential role in proliferation and migration of pulmonary arterial smooth muscle cells , 2015, Scientific Reports.

[66]  Baofeng Yang,et al.  MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression. , 2015, The international journal of biochemistry & cell biology.

[67]  H. Uzun,et al.  Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension , 2015, Clinical and experimental hypertension.

[68]  N. Morrell,et al.  A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension. , 2015, American journal of respiratory and critical care medicine.

[69]  C. Arenz,et al.  MicroRNA-145-targeted drug and its preventive effect on pulmonary arterial hypertension (patent WO2012153135 A1) , 2015, Expert opinion on therapeutic patents.

[70]  Yang Yang,et al.  MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor γ dependent Hsp90-eNOS signaling and nitric oxide production. , 2015, Biochemical and biophysical research communications.

[71]  M. Gassmann,et al.  Featured Article: microRNA-125a in pulmonary hypertension: Regulator of a proliferative phenotype of endothelial cells , 2015, Experimental biology and medicine.

[72]  M. Gassmann,et al.  The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A. , 2015, The international journal of biochemistry & cell biology.

[73]  J. Yuan,et al.  Loss of microRNA-17∼92 in smooth muscle cells attenuates experimental pulmonary hypertension via induction of PDZ and LIM domain 5. , 2015, American journal of respiratory and critical care medicine.

[74]  Daniel G. Anderson,et al.  Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron–sulfur deficiency and pulmonary hypertension , 2015, EMBO molecular medicine.

[75]  A. Evangelou,et al.  Association of High Blood Pressure with Body Mass Index, Smoking and Physical Activity in Healthy Young Adults , 2015, The open cardiovascular medicine journal.

[76]  C. Carda,et al.  Role of Circulating miRNAs as Biomarkers in Idiopathic Pulmonary Arterial Hypertension: Possible Relevance of miR-23a , 2015, Oxidative medicine and cellular longevity.

[77]  Bo Zhang,et al.  miR-29a-3p Attenuates Hypoxic Pulmonary Hypertension by Inhibiting Pulmonary Adventitial Fibroblast Activation , 2015, HYPERTENSION.

[78]  Sebastien Bonnet,et al.  A miR-208–Mef2 Axis Drives the Decompensation of Right Ventricular Function in Pulmonary Hypertension , 2015, Circulation research.

[79]  L. Nelin,et al.  MKP‐1 is a target of miR‐210 and mediate the negative regulation of miR‐210 inhibitor on hypoxic hPASMC proliferation , 2015, Cell biology international.

[80]  F. Potus,et al.  microRNA and Pulmonary Hypertension. , 2015, Advances in experimental medicine and biology.

[81]  Qinbo Yang,et al.  MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation. , 2014, International journal of cardiology.

[82]  W. Kuebler,et al.  The MicroRNA-130/301 Family Controls Vasoconstriction in Pulmonary Hypertension* , 2014, The Journal of Biological Chemistry.

[83]  Chen Li,et al.  MicroRNA 648 Targets ET-1 mRNA and Is Cotranscriptionally Regulated with MICAL3 by PAX5 , 2014, Molecular and Cellular Biology.

[84]  Chen Li,et al.  Peroxisome Proliferator-activated Receptor-α-mediated Transcription of miR-199a2 Attenuates Endothelin-1 Expression via Hypoxia-inducible Factor-1α* , 2014, The Journal of Biological Chemistry.

[85]  Wei Han,et al.  Effect of miR-29a Inhibition on Ventricular Hypertrophy Induced by Pressure Overload , 2014, Cell Biochemistry and Biophysics.

[86]  S. Provencher,et al.  miRNAs in PAH: biomarker, therapeutic target or both? , 2014, Drug discovery today.

[87]  W. Wallace,et al.  Systems-level regulation of microRNA networks by miR-130 / 301 promotes pulmonary hypertension , 2022 .

[88]  C. Couture,et al.  Role for DNA Damage Signaling in Pulmonary Arterial Hypertension , 2014, Circulation.

[89]  A. Levine,et al.  DNA methylation silences miR-132 in prostate cancer , 2013, Oncogene.

[90]  E. Paquet,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[91]  A. Hata,et al.  SMAD proteins control DROSHA-mediated microRNA maturation , 2008, Nature.